• Home
  • Store
    • Newsletter Subscriptions
    • Multimedia
    • Books
    • eBooks
    • ABPN SA Courses
    • Social Work Courses
  • CME Center
  • Multimedia
    • Podcast
    • Webinars
    • Blog
    • Psychiatry News Videos
    • Medication Guide Videos
  • Newsletters
    • General Psychiatry
    • Child Psychiatry
    • Addiction Treatment
    • Hospital Psychiatry
    • Geriatric Psychiatry
    • Psychotherapy and Social Work
  • FAQs
  • Med Fact Book App
  • Log In
  • Register
  • Welcome
  • Sign Out
  • Subscribe
Home » What Can Our Pregnant Patients Do to Prevent Mental Illness in Their Children?

What Can Our Pregnant Patients Do to Prevent Mental Illness in Their Children?

March 29, 2019
Robert Freedman, MD
From The Carlat Psychiatry Report
Issue Links: Learning Objectives | Editorial Information | PDF of Issue

Robert Freedman, MD Robert Freedman, MD

Professor and Former Chairman, Department of Psychiatry, University of Colorado-Denver. Editor Emeritus, American Journal of Psychiatry.

Dr. Freedman has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

TCPR: Expectant mothers often want to come off psychiatric medications. From their perspective, mental illness takes place in the brain and won’t affect the fetus, while psychiatric medications are quite dangerous. What can we tell them?

Dr. Freedman: There are risks with psychiatric medications, but the only one that is contraindicated in pregnancy is valproate (Depakote), which has been linked to neural tube deficits and lower IQ. On the other hand, untreated mental illness also affects the developing baby, and this risk isn’t limited to postpartum disorders. During pregnancy, untreated depression significantly increases the risk that the infant will fail to develop adequate levels of cerebral inhibition. That’s a measure of the infant’s ability to filter out irrelevant stimuli, and it’s the first sign that development is not on an optimal track (Hunter SK et al, Schizophr Bull 2011;37(6):1200–1208).


TCPR: How do we know that problem is caused by prenatal depression, rather than depressive symptoms that continue after childbirth?

Dr. Freedman: The reason we study cerebral inhibition is that it can be measured very early—1 month after birth—and that helps separate out the effects of depression during pregnancy from the psychosocial consequences of living with a depressed mother. When depression is treated during pregnancy, even with antidepressants, we don’t see this problem in development. So as best we can tell, it’s depression during pregnancy that’s causing it.

TCPR: What else can expectant mothers do to prevent psychiatric problems in the developing baby?
Dr. Freedman: Avoid drugs, including nicotine and marijuana. Good nutrition. Also flu shots, because infections are one of the leading risk factors for schizophrenia (Brown AS et al, Am J Psychiatry 2010;167(3):261–280). The shot comes as an inactivated virus formulated for pregnancy. And, of course, prenatal vitamins. Most of these have folate and vitamins A and D, which are critical to brain development and help prevent schizophrenia, but one nutrient they often miss is choline. In 2017, the American Medical Association (AMA) recommended adding choline.


TCPR: How did the AMA come to that decision?
Dr. Freedman: Choline has been studied in pregnancy for over a decade. It improves the infant’s cognitive ability and has no side effects at the doses studied. Choline is an agonist at the alpha-7 nicotinic receptors, which are implicated in the development of schizophrenia. Our group has found that choline supplementation during pregnancy prevents early signs of future schizophrenia and other disorders, such as social isolation and attention problems, at 3.5 years of age. Another group has now found that choline supplements prevent early cognitive deficits in children of mothers who drink alcohol in pregnancy.

TCPR: Tell us more about what you found.
Dr. Freedman: With the FDA’s approval, we conducted a randomized clinical trial of choline supplementation in 100 pregnant women. So far we’ve followed the children up to age 4, and the choline group has less social isolation and better attention. Those two areas tend to be abnormal in people at that age who later develop schizophrenia, but we don’t know what will happen in 20 years (Ross RG et al, Am J Psychiatry 2013;170(3):290–298).

TCPR: Are the data good enough to start using choline clinically?
Dr. Freedman: I can’t say. On the one hand, a fetus has only one chance at brain development, and deficits occurring in fetal life are not reversed after birth. For example, folic acid before birth prevents spina bifida. After birth, folic acid will not close the spine that failed to close during fetal development. So it’s very important for people to be aware of choline. On the other hand, the evidence is still coming in. Other groups have found similar results, with improvements in cognition and behavior at ages 1 to 4 years.

TCPR: Are prenatal vitamins starting to add choline?
Dr. Freedman: Most popular brands, like One-A-Day Prenatal, do not. A few vitamin brands have it, but in very small doses like 10–50 mg. The FDA’s recommendation for dietary choline is 550 mg daily, but the average Western diet only yields about 300 mg of choline. So most women—about two-thirds—are choline-deficient. (Editor’s note: Dr. Freedman has no financial or other interest in choline products.)

TCPR: How would you supplement choline in pregnancy?
Dr. Freedman: We actually use a precursor, phosphatidylcholine (PIP), and the dose we use in pregnancy is 6,300 mg daily. That converts to 900 mg of choline. PIP is the main dietary source of choline, and there are no known risks with PIP (eg, Country Life Phosphatidylcholine, 600 mg capsules, dose = 10 capsules/day, $375/pregnancy). The pure form, choline bitartrate, is cheaper, but it can sometimes form a bolus in the large intestine, where bacteria metabolize it into a foul-smelling and sometimes toxic product (eg, Nature’s Way Choline Bitartrate, 500 mg capsules = 204 mg choline, dose = 5 capsules/day, $98/pregnancy).

TCPR: When is the optimal time to supplement?
Dr. Freedman: Earlier is better. A woman could start while trying to become pregnant. If she does start early, she should understand that spontaneous abortions are common and not something that’s caused by supplementation.

TCPR: Can a woman get choline from diet alone?
Dr. Freedman: Yes, but it’s not easy. It would take a serving of calf’s liver every day, or 6 hard-boiled eggs a day, or 1–2 servings of steak a day.

TCPR: Thank you for your time, Dr. Freedman.

Editor’s note: Dr. Freedman maintains an educational site for patients at www.prenataldoctoradvice.com.


General Psychiatry
KEYWORDS practice_tools_and_tips pregnancy
    Tcpr march qa2 robert freedman photo 1
    Robert Freedman, MD

    More from this author
    www.thecarlatreport.com
    Issue Date: March 29, 2019
    SUBSCRIBE NOW
    Table Of Contents
    CME Post-Test - Parenting, Pregnancy, and Prevention, TCPR, March 2019
    Ask the Editor: Should You Prescribe Lithium to Suicidal Patients?
    Amphetamines Stand Out in ADHD
    What Can Our Pregnant Patients Do to Prevent Mental Illness in Their Children?
    Parenting Strategies for Patients With Mental Illness
    A Second Look at Genetic Testing
    DOWNLOAD NOW
    Featured Book
    • MFB7e_Print_App_Access.png

      Medication Fact Book for Psychiatric Practice, Seventh Edition (2024) - Regular Bound Book

      The updated 2024 reference guide covering the most commonly prescribed medications in psychiatry.
      READ MORE
    Featured Video
    • KarXT (Cobenfy)_ The Breakthrough Antipsychotic That Could Change Everything.jpg
      General Psychiatry

      KarXT (Cobenfy): The Breakthrough Antipsychotic That Could Change Everything

      Read More
    Featured Podcast
    • shutterstock_2622607431.jpg
      General Psychiatry

      Should You Test MTHFR?

      MTHFR is a...
      Listen now
    Recommended
    • Join Our Writing Team

      July 18, 2024
      WriteForUs.png
    • Insights About a Rare Transmissible Form of Alzheimer's Disease

      February 9, 2024
      shutterstock_2417738561_PeopleImages.com_Yuri A.png
    • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

      May 24, 2024
      DEA_Checkbox.png
    • Join Our Writing Team

      July 18, 2024
      WriteForUs.png
    • Insights About a Rare Transmissible Form of Alzheimer's Disease

      February 9, 2024
      shutterstock_2417738561_PeopleImages.com_Yuri A.png
    • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

      May 24, 2024
      DEA_Checkbox.png
    • Join Our Writing Team

      July 18, 2024
      WriteForUs.png
    • Insights About a Rare Transmissible Form of Alzheimer's Disease

      February 9, 2024
      shutterstock_2417738561_PeopleImages.com_Yuri A.png
    • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

      May 24, 2024
      DEA_Checkbox.png

    About

    • About Us
    • CME Center
    • FAQ
    • Contact Us

    Shop Online

    • Newsletters
    • Multimedia Subscriptions
    • Books
    • eBooks
    • ABPN Self-Assessment Courses

    Newsletters

    • The Carlat Psychiatry Report
    • The Carlat Child Psychiatry Report
    • The Carlat Addiction Treatment Report
    • The Carlat Hospital Psychiatry Report
    • The Carlat Geriatric Psychiatry Report
    • The Carlat Psychotherapy Report

    Contact

    carlat@thecarlatreport.com

    866-348-9279

    PO Box 626, Newburyport MA 01950

    Follow Us

    Please see our Terms and Conditions, Privacy Policy, Subscription Agreement, Use of Cookies, and Hardware/Software Requirements to view our website.

    © 2025 Carlat Publishing, LLC and Affiliates, All Rights Reserved.